RecruitingNCT06082284

A Cross-sectional Study on the Positive Rate of M Protein Based on a Highly Sensitive Serum M Protein Detection Method.

A Cross-sectional Study on the Positive Rate of Monoclonal Immunoglobulin (M Protein) in the Serum of Patients Seeking Medical Treatment in Tertiary Hospitals Based on a Highly Sensitive Serum M Protein Detection Method.


Sponsor

Zhujiang Hospital

Enrollment

10,000 participants

Start Date

Oct 1, 2023

Study Type

OBSERVATIONAL

Conditions

Summary

By using a highly sensitive serum M protein detection method based on the MALDI-TOF MS platform, serum monoclonal immunoglobul (M protein) in detection was performed on the visiting patients to explore the positive rate of serum M protein and its distribution in different departments. And exploring the correlation analysis between the relative concentration of serum M protein based on the above highly sensitive methods and clinical indicators.


Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This study uses a highly sensitive blood test to measure how common abnormal proteins called "M proteins" are in the general hospital population. M proteins in the blood can be an early sign of certain blood disorders. Researchers want to understand how often these are found using a newer, more sensitive testing method. **You may be eligible if...** - You are 18 years or older - You are being seen at Zhujiang Hospital (in China) as an outpatient, emergency, or inpatient - There is leftover blood (serum) from your routine tests available and you have given general consent for research use **You may NOT be eligible if...** - You have already been diagnosed with a blood cancer involving plasma cells or B lymphocytes (such as myeloma or lymphoma) - Your blood sample was stored improperly or has been repeatedly frozen and thawed Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.


Locations(1)

Zhujiang Hospital of Southern Medical University

Guangzhou, Guangdong, China

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06082284


Related Trials